Skip to content
Terminus Peptides

Policy

Accessibility statement

The accessibility standard this site aims for, and what has been tested.

Last updated 17 August 2026.

This statement describes the accessibility of the Terminus Peptides website. It has not been reviewed by an accessibility professional and no independent audit has been commissioned.

Standard

The site aims to meet WCAG 2.2 level AA. It is built with semantic HTML, operable by keyboard throughout, and does not rely on colour alone to convey information: evidence levels and regulatory statuses carry text labels as well as visual treatment.

Measures taken

  • A skip-to-content link is the first focusable element on every page.
  • Focus is always visible and is never removed.
  • Body text meets or exceeds 16px, and the layout reflows without horizontal scrolling at 320px and at 200% zoom.
  • Motion is restrained and is suppressed entirely under a reduced-motion preference.
  • Form fields carry associated labels, and errors are announced rather than shown only in colour.
  • Text and interface colours were selected to meet AA contrast ratios against the backgrounds they appear on.

Known gaps

  • No independent audit or assistive-technology user testing has been carried out.
  • Feedback route and target response time: [VERIFICATION REQUIRED BEFORE PUBLICATION].
  • Enforcement procedure statement, where required: [VERIFICATION REQUIRED BEFORE PUBLICATION].

Feedback

Accessibility problems can be reported through the contact page using the “website issue” category. Reports that describe what you were trying to do, and what happened instead, are the most useful.